VRDN
Viridian Therapeutics (VRDN) Earnings Dates & Reports
Viridian Therapeutics (VRDN) Most Recent Earnings
Report DateAug 6, 2025
Period EndingQ2 2025
Est. EPS-$0.98
Actual EPS-$1
EarningsMiss
Viridian Therapeutics (VRDN) Earnings
View the latest Viridian Therapeutics (VRDN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Viridian Therapeutics (VRDN)
Order type
Buy in
Order amount
Est. shares
0 shares
Viridian Therapeutics (VRDN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Viridian Therapeutics (VRDN) Latest Earnings
The value each VRDN share was expected to gain vs. the value each share gained.
Viridian Therapeutics (VRDN) reported its most recent earnings on Aug 6, 2025 for Q2 2025, posting earnings per share (EPS) of -$1. This exceeded analysts' expectations of -$0.98 by 2.04%, marking a Miss.
For comparison, Viridian Therapeutics reported EPS of -$1.02 in the same quarter last year.
The company is expected to announce its next earnings report on 11/11/2025, with analysts projecting an EPS of -$0.88.
Viridian Therapeutics (VRDN) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Nov 11, 2025 | -$0.88 | Next earnings call Nov. 11, 2025 | ||
Q2 2025Aug 6, 2025 | -$0.98 | -$1.00 | +2.04% | |
Q1 2025May 6, 2025 | -$0.96 | -$0.87 | -9.37% | |
Q4 2024Feb 27, 2025 | -$1.00 | -$0.81 | -19.00% | |
Q3 2024Nov 12, 2024 | -$1.05 | -$1.15 | +9.52% | |
Viridian Therapeutics (VRDN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Viridian Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 6, 2025 | — | — | — |
May 6, 2025 | — | — | — |
Feb 27, 2025 | — | — | — |
Nov 12, 2024 | — | — | — |
Viridian Therapeutics (VRDN) Earnings FAQs
Viridian Therapeutics (VRDN) last reported earnings on Aug 6, 2025 for Q2 2025, posting an EPS of -$1, which Miss the estimate of -$0.98 by 2.04%.
For Q2 2025, Viridian Therapeutics (VRDN) reported an EPS of -$1, missing analysts' estimate of -$0.98 by 2.04%.
For Q2 2025, Viridian Therapeutics (VRDN) Miss expectations with an actual EPS of -$1 vs. an estimated EPS of -$0.98.
Following the last earnings report on Aug 6, 2025, Viridian Therapeutics (VRDN)'s stock price moved — from — to —.
The next Viridian Therapeutics (VRDN) earnings call is scheduled for Nov. 11, 2025, where executives will discuss financial results and outlook.